INOVIQ LTD(IIQ.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

IIQ.AU INOVIQ LTD

Closed 01-13 16:12:00 AEDT

0.50

+0.00

0.00%

High0.50	Low0.49	Vol143.83K
Open0.50	D1 Closing0.50	Amplitude0.61%
Mkt Cap55.21M	Tradable Cap42.97M	Total Shares111.53M
T/O71.17K	T/O Rate0.17%	Tradable Shares86.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"IIQ.AU","market":"AU","secType":"STK","nameCN":"INOVIQ LTD","latestPrice":0.495,"timestamp":1736745120000,"preClose":0.495,"halted":0,"volume":143832,"delay":0,"nameEN":"INOVIQ LTD","floatShares":86803518,"shares":111526702,"eps":-0.070915,"marketStatus":"Closed","change":0,"latestTime":"01-13 16:12:00 AEDT","open":0.495,"high":0.495,"low":0.492,"amount":71167,"amplitude":0.006061,"askPrice":0.495,"askSize":39822,"bidPrice":0.49,"bidSize":24880,"shortable":3,"etf":0,"ttmEps":-0.070915,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1736809200000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.495,"openAndCloseTimeList":[[1736722800000,1736744400000]],"volumeRatio":1.878065,"lotSize":1,"tradeCurrency":"AUD"},"requestUrl":"/m/hq/s/IIQ.AU/tweets","defaultTab":"tweets","newsList":[{"id":"2491500187","title":"INOVIQ: Conceptual success killing breast cancer cells with exosomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2491500187","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491500187?lang=en_us&edition=full_marsco","pubTime":"2024-12-16 07:56","pubTimestamp":1734306960,"startTime":"0","endTime":"0","summary":"INOVIQ Ltd  has reported early-stage in-vitro success using exosomes from natural killer cells to attack breast cancer cells.Natural killer  cells are what they sound like –naturally occurring elements of the human immune system that use enzymes to attack viruses in the body. Exosomes are released by cells in the body and carry proteins and DNA to other cells.So, in short, INOVIQ is trying to stimulate NK cells to produce exosomes to target breast cancer cells in a petri dish – and according to the company, it’s working. So far, that only shows partial evidence in support of a ‘proof of concept.’。That concept sees INOVIQ being able to attach a chimeric antigen receptor  – a lab-created protein – to the exosomes produced by the NK cells.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/inoviq-conceptual-success-killing-breast-cancer-cells-with-exosomes-2024-12-16/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7095","BK4230","IIQ.AU","CAR","BK7503","BK7002","BK7124","IND.AU","BK4022","CAR.AU"],"gpt_icon":0},{"id":"2489473185","title":"INOVIQ Completes Disease Specificity Testing for Breast Cancer Blood Test; Shares Rise 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489473185","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489473185?lang=en_us&edition=full_marsco","pubTime":"2024-12-06 13:35","pubTimestamp":1733463334,"startTime":"0","endTime":"0","summary":"INOVIQ (ASX:IIQ) has completed disease specificity testing for its blood test designed to detect breast cancer, according to a Friday filing with the Australian bourse.The test, which combines a monoc","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7124","IIQ.AU"],"gpt_icon":0},{"id":"2489288171","title":"3 ASX biotech shares rocketing 10% to 26% on BIG news!","url":"https://stock-news.laohu8.com/highlight/detail?id=2489288171","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489288171?lang=en_us&edition=full_marsco","pubTime":"2024-12-05 09:28","pubTimestamp":1733362088,"startTime":"0","endTime":"0","summary":"Three ASX biotech shares are setting the bar high today. The companies have grabbed investor interest today, with each releasing promising news. And this is sending them racing ahead of the 0.2% gains","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2024/12/05/3-asx-biotech-shares-rocketing-10-to-26-on-big-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU1894683264.USD","IIQ.AU","BK7067","CMS","BIG","LU1894683348.USD","BK4208","BK4588","BK7124","LU2637428348.USD","BK7508","BK4585","XAO.AU","BK7126","LU2346227817.USD","RAC.AU","BK4220","LDX.AU","BK4114"],"gpt_icon":0},{"id":"2489175417","title":"INOVIQ completes disease specificity testing for breast cancer blood test","url":"https://stock-news.laohu8.com/highlight/detail?id=2489175417","media":"Grafa","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489175417?lang=en_us&edition=full_marsco","pubTime":"2024-12-05 09:06","pubTimestamp":1733360805,"startTime":"0","endTime":"0","summary":"INOVIQ  has completed the disease specificity testing for its groundbreaking breast cancer blood test.INOVIQ's test, a hybrid assay combining a monoclonal antibody with the company's SubB2M detection reagent, demonstrated improvements in accurately detecting breast cancer across all stages.The test achieved 81% sensitivity and 93% specificity, showcasing its ability to effectively differentiate breast cancer from non-cancer diseases.This success paves the way for its use in breast cancer monitoring, providing potential relief in reducing false positives.CEO Leearne Hinch stated, \"The test is being developed as an LDT for the US market initially. Demonstrating the specificity of neuCA15-3 for breast cancer detection completes another component of the test validation.\". Chairman David Williams added, \"The aim is to demonstrate that our SubB2M technology can be used as a detection reagent to enhance the performance of multiple existing cancer biomarker tests.\". INOVIQ is engaged in develo","market":null,"thumbnail":"https://images.grafa.com/grafa/media-health-inoviq-completes-disease-specificity-testing-for-breast-cancer-blood-test-325494-638689576056965116.jpeg","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-health-inoviq-completes-disease-specificity-testing-for-breast-cancer-blood-test-325494-638689576056965116.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://grafa.com/news/health-inoviq-completes-disease-specificity-testing-for-breast-cancer-blood-test-325494?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","IIQ.AU"],"gpt_icon":0},{"id":"2488934329","title":"ASX Market Close: Index sets a new closing record | December 3, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2488934329","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488934329?lang=en_us&edition=full_marsco","pubTime":"2024-12-03 14:28","pubTimestamp":1733207280,"startTime":"0","endTime":"0","summary":"The ASX200 closed up 0.56% at 8,495 points, marking a new closing record for the local index. The bourse has risen more than 19% over the same time last year, as the ASX continues its stellar run.Health Care was the best performer, up 1.2%, followed by Discretionary, up 1.05%, and Industrials, up 0.93%.Block Inc  closed up 5.82% after leading a surge in tech stocks. The company ranks as the biggest tech player on the ASX and jumped to an all-time high of $144.36, before paring gains to close at $143.94.Hazer Group  closed up 6.41% on receipt of a $6.2 million grant from the WA government. The funding will progress the company’s commercial reactor scale-up program and much of its other work slated for the next two years.Biotech play INOVIQ  finished up 10.75% after yielding positive results from its blood test to screen for ovarian cancer, with more than 94% accuracy.Macmahon Holdings  closed down 1.35% on release of an investor presentation at the Canaccord Mining Services Series. The ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-index-sets-a-new-closing-record-december-3-2024-2024-12-03/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["MAH.AU","HZR.AU","SQ2.AU","PDI.AU","BK7104","BK7036","BK7124","BK7093","BK7033","BK7095","IIQ.AU","ZIP.AU","BK7158"],"gpt_icon":1},{"id":"2488399779","title":"INOVIQ achieves over 94% accuracy in EXO-OC blood test for ovarian cancer screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2488399779","media":"Grafa","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488399779?lang=en_us&edition=full_marsco","pubTime":"2024-12-03 09:44","pubTimestamp":1733190250,"startTime":"0","endTime":"0","summary":"INOVIQ  announced the independent validation of its EXO-OC blood test for ovarian cancer screening, achieving an impressive accuracy rate of over 94%.This advancement promises the potential in enhancing early detection and patient outcomes for ovarian cancer.The study involved over 500 blood samples, with exosomes isolated using INOVIQ's high-throughput robotic platform and biomarkers analysed at the University of Queensland's Centre for Extracellular Vesicle Nanomedicine.Professor Carlos Salomon Gallo, Director of the UQ Centre, highlighted the study's success, \"This study demonstrated that the EXO-OC test identified ovarian cancer across all stages with an overall accuracy of over 94%. Notably, the EXO-OC test is particularly accurate in identifying early stages of ovarian cancer.\". INOVIQ's CEO, Leearne Hinch, stated, \"Early detection enables timely intervention, which is crucial for increasing survival rates and reducing disease progression.\". INOVIQ plans to optimise the test on a","market":null,"thumbnail":"https://images.grafa.com/grafa/media-health-inoviq-achieves-over-94--accuracy-in-exo-oc-blood-test-for-ovarian-cancer-screening-323634-638687870502467547.jpeg","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-health-inoviq-achieves-over-94--accuracy-in-exo-oc-blood-test-for-ovarian-cancer-screening-323634-638687870502467547.jpeg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://grafa.com/news/health-inoviq-achieves-over-94--accuracy-in-exo-oc-blood-test-for-ovarian-cancer-screening-323634?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","IIQ.AU"],"gpt_icon":1},{"id":"2463215132","title":"INOVIQ Independent Non-Executive Director Acquires 49% More Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2463215132","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2463215132?lang=en_us&edition=full_marsco","pubTime":"2024-08-30 04:44","pubTimestamp":1724964251,"startTime":"0","endTime":"0","summary":"Whilst it may not be a huge deal, we thought it was good to see that the INOVIQ Ltd  Independent Non-Executive Director, Robert Johnston, recently bought AU$100k worth of stock, for AU$0.50 per share. That purchase might not be huge but it did increase their holding by 49%.In fact, the recent purchase by Robert Johnston was the biggest purchase of INOVIQ shares made by an insider individual in the last twelve months, according to our records. Even though the purchase was made at a significantly lower price than the recent price , we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/wPCaEqo0Eoh8gNU.SS4ZzA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5bcfe52095f73041f79c669b593d7118"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inoviq-independent-non-executive-director-204411613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7124","IIQ.AU"],"gpt_icon":0},{"id":"2461371042","title":"INOVIQ Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag","url":"https://stock-news.laohu8.com/highlight/detail?id=2461371042","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2461371042?lang=en_us&edition=full_marsco","pubTime":"2024-08-23 05:15","pubTimestamp":1724361304,"startTime":"0","endTime":"0","summary":"ASX:IIQ Earnings and Revenue History August 22nd 2024. All figures shown in the chart above are for the trailing 12 month  period. Revenue missed analyst estimates by 41%. Earnings per share  exceeded analyst estimates by 28%.Looking ahead, revenue is forecast to grow 82% p.a. on average during the next 2 years, compared to a 6.1% growth forecast for the Healthcare industry in Australia.The company's share price is broadly unchanged from a week ago.We should say that we've discovered 5 warning signs for INOVIQ that you should be aware of before investing here.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/5Vpve0Pc2F3m_L3fs2p_dQ--~B/aD02MzY7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/inoviq-full-2024-earnings-eps-211504143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["IIQ.AU"],"gpt_icon":0},{"id":"2460161900","title":"INOVIQ says it has found a way to test blood for Parkinson’s Disease – after Alzheimer’s success in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2460161900","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460161900?lang=en_us&edition=full_marsco","pubTime":"2024-08-20 08:59","pubTimestamp":1724115540,"startTime":"0","endTime":"0","summary":"If you’re looking for a reason why INOVIQ  shares jumped 6% out the gate on Tuesday, it’s this – after announcing similar success for Alzheimer’s patients in June, the company now says it can test blood for Parkinson’s.it all boils down to Inoviq’s software-based proprietary platform, ‘NEURO-NET,’ which ultimately creates a computerised “protein fingerprint” from blood sample data that can differentiate between donors with “normal healthy blood” and those with target conditions.Both Alzheimer’s Disease , and now Parkinson’s Disease , are target conditions INOVIQ states NEURO-NET is more than able to identify.The implications are obvious: INOVIQ may have just cracked the code to diagnosing Parkinson’s before the condition has a chance to begin reducing quality of life – or before patients let any more time pass.“NEURO-NET enriches known protein biomarkers of neurodegenerative diseases by 5-8-fold compared to measuring them directly from blood, greatly increasing the potential for earlie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/inoviq-says-it-has-found-a-way-to-test-blood-for-parkinsons-disease-after-alzheimers-success-in-june-2024-08-20/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["IIQ.AU","LU1169590202.USD","BK4023","PD","LU1169589451.USD","BK7124"],"gpt_icon":0},{"id":"2449345402","title":"INOVIQ (ASX:IIQ) raises $9.4M to boost cancer research and EXO-NET development","url":"https://stock-news.laohu8.com/highlight/detail?id=2449345402","media":"Grafa","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2449345402?lang=en_us&edition=full_marsco","pubTime":"2024-07-05 09:21","pubTimestamp":1720142472,"startTime":"0","endTime":"0","summary":"INOVIQ completed its share purchase plan, with total applications amounting to $7.3 million, surpassing its initial target of $2 million.The company accepted allocations up to $2.4 million, resulting in a total capital raise of $9.4 million, including a prior placement to institutional investors.Eligible shareholders were offered the chance to purchase new shares at 50 cents per share. Investors received one free quoted option for every two new shares issued, with an exercise price of $1 expiring on July 8, 2026.The raised funds will be allocated to advancing EXO-NET research tools, developing pipeline diagnostics, and expediting cancer therapeutics research.","market":null,"thumbnail":"https://images.grafa.com/grafa/media-243974-638557319463308860.png","type":0,"news_type":0,"thumbnails":["https://images.grafa.com/grafa/media-243974-638557319463308860.png"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://grafa.com/news/inoviq--asx-iiq--raises--9-4m-to-boost-cancer-research-and-exo-net-development-243974?referralcode=A314DFDBE96C354756A893C6E3E02493","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IIQ.AU","BK7124"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0571},{"period":"1month","weight":-0.0571},{"period":"3month","weight":0.0645},{"period":"6month","weight":-0.1466},{"period":"1year","weight":-0.2143},{"period":"ytd","weight":-0.0388}],"compareEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":-0.0038},{"period":"3month","weight":0.0272},{"period":"6month","weight":0.0594},{"period":"1year","weight":0.1592},{"period":"ytd","weight":0.0067}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.015598},{"month":2,"riseRate":0,"avgChangeRate":-0.05069},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.132215},{"month":4,"riseRate":0,"avgChangeRate":-0.090689},{"month":5,"riseRate":0.666667,"avgChangeRate":0.247116},{"month":6,"riseRate":0.666667,"avgChangeRate":0.261375},{"month":7,"riseRate":0,"avgChangeRate":-0.134363},{"month":8,"riseRate":0,"avgChangeRate":-0.120757},{"month":9,"riseRate":0.666667,"avgChangeRate":0.004106},{"month":10,"riseRate":0.333333,"avgChangeRate":0.017857},{"month":11,"riseRate":1,"avgChangeRate":0.116954},{"month":12,"riseRate":0.25,"avgChangeRate":-0.096304}],"exchange":"ASX","name":"INOVIQ LTD","nameEN":"INOVIQ LTD"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INOVIQ LTD(IIQ.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INOVIQ LTD(IIQ.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INOVIQ LTD,IIQ.AU,INOVIQ LTD股票,INOVIQ LTD股票老虎,INOVIQ LTD股票老虎国际,INOVIQ LTD行情,INOVIQ LTD股票行情,INOVIQ LTD股价,INOVIQ LTD股市,INOVIQ LTD股票价格,INOVIQ LTD股票交易,INOVIQ LTD股票购买,INOVIQ LTD股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INOVIQ LTD(IIQ.AU),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INOVIQ LTD(IIQ.AU) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction